This inventor holds 1 USPTO granted patent. Top assignee: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Qingrou Li: Inventor in Biopharmaceutical Innovation.
Introduction
Qingrou Li is an inventor associated with Pudong New Area, China, and Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. His listed patent work concerns antibody-based approaches with potential therapeutic applications.
Latest Patents
The provided information lists one patent for Li: “Human IL-33 Antibodies, Preparation Method and Conjugates Thereof and Method of Use Thereof for Treatment.” The patent addresses human IL-33 antibodies, their preparation and conjugates, and methods for their therapeutic use. Li is credited with 1 patent in the supplied data.
Career Highlights
Li’s listed invention is connected to Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd., a company working in the biopharmaceutical field. The patent’s focus on antibodies and treatment methods reflects research directed toward therapeutic development.
Collaborations
The supplied information identifies Wei Guo and Xuesai Zhang as Li’s coworkers. Their names are associated with the same professional context, though specific roles in the patent are not provided.
Conclusion
Qingrou Li’s listed patent highlights his contribution to antibody-related therapeutic innovation through work associated with Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile